BioInvent International AB publ announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was SEK 5.288 million compared to SEK 15.648 million a year ago. Operating loss was SEK 57.108 million compared to SEK 39.098 million a year ago. Net loss was SEK 57.291 million compared to SEK 39.335 million a year ago. Basic loss per share from continuing operations was SEK 0.98 compared to SEK 2 a year ago. For the half year, sales was SEK 11.488 million compared to SEK 32.362 million a year ago. Operating loss was SEK 137.073 million compared to SEK 72.069 million a year ago. Net loss was SEK 137.079 million compared to SEK 71.977 million a year ago. Basic loss per share from continuing operations was SEK 2.75 compared to SEK 3.5 a year ago.